These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16481301)

  • 1. Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray.
    Xu L; Li YM; Yu CH; Li L; Liu YS; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):138-42. PubMed ID: 16481301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of expression of p53, p16, and cyclooxygenase 2 in pancreatic cancer by tissue microarray and correlation among these three genes].
    Li YM; Yu ZH; Li L; Xu P; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):939-42. PubMed ID: 16759529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray.
    Liu YS; Yu CH; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Li YM; Jun Gao H
    J Dig Dis; 2007 Aug; 8(3):133-8. PubMed ID: 17650224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of tissue microarray p53, p16 and cyclooxygenase-2 in gastric cancer].
    Yu CH; Li L; Li YM; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):658-60. PubMed ID: 17074152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
    Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
    Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
    J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.
    Müller-Decker K; Fürstenberger G; Annan N; Kucher D; Pohl-Arnold A; Steinbauer B; Esposito I; Chiblak S; Friess H; Schirmacher P; Berger I
    Gastroenterology; 2006 Jun; 130(7):2165-78. PubMed ID: 16762637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
    Karsai S; Abel U; Roesch-Ely M; Affolter A; Hofele C; Joos S; Plinkert PK; Bosch FX
    J Pathol; 2007 Feb; 211(3):314-22. PubMed ID: 17152048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
    Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY
    Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
    Murao K; Kubo Y; Ohtani N; Hara E; Arase S
    Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas.
    Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients.
    Dong M; Nio Y; Tamura K; Song MM; Guo KJ; Guo RX; Dong YT
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):279-84. PubMed ID: 10750666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
    Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
    Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.
    Yanokura M; Banno K; Susumu N; Kawaguchi M; Kuwabara Y; Tsukazaki K; Aoki D
    Anticancer Res; 2006; 26(2A):851-6. PubMed ID: 16619479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer.
    Lim SC; Lee TB; Choi CH; Ryu SY; Min YD; Kim KJ
    J Surg Oncol; 2008 Jan; 97(1):51-6. PubMed ID: 17929263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cyclooxygenase-2 expression associated with inflammatory cellular infiltration in elderly patients with vulvar cancer.
    Lee TS; Jeon YT; Kim JW; Won JK; Park NH; Park IA; Juhnn YS; Kang SB; Lee HP; Song YS
    Ann N Y Acad Sci; 2007 Jan; 1095():143-53. PubMed ID: 17404027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice.
    Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B
    J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of p16 protein expression loss and aberrant p53 protein expression in pancreatic cancer.
    Jeong J; Park YN; Park JS; Yoon DS; Chi HS; Kim BR
    Yonsei Med J; 2005 Aug; 46(4):519-25. PubMed ID: 16127777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.